Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of TNXP: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5547−8
Shares4.34M5.59M+1.26M (+28.9%)
Value$6.08M$2.99M−$3.09M (−50.9%)

New holders (8)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TNXP in Q3 2022
InstitutionSharesValue% of portfolio
Hudson Bay Capital Management LP230,000$123.0K0.00%
Two Sigma Investments, LP201,649$108.0K0.00%
Virtu Financial LLC129,891$69.0K0.01%
Edmond de Rothschild Holding S.A.9,375$5.00K0.00%
Hallmark Capital Management Inc1$00.00%
Tradewinds Capital Management, LLC1$00.00%
Twin Lakes Capital Management, LLC18$00.00%
China Universal Asset Management Co., Ltd.419$00.00%

Sold out (16)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q2 2022 and filed for Q3 2022 without it.